RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,181,417 | +25.6% | 51,534 | -9.6% | 0.00% | +100.0% |
| Q2 2023 | $940,408 | +0.6% | 57,029 | +8.8% | 0.00% | 0.0% |
| Q1 2023 | $935,208 | -9.0% | 52,422 | +48.5% | 0.00% | -50.0% |
| Q4 2022 | $1,028,111 | +29.0% | 35,306 | +8.6% | 0.00% | +100.0% |
| Q3 2022 | $797,000 | +499.2% | 32,520 | +1.8% | 0.00% | – |
| Q2 2022 | $133,000 | -76.2% | 31,946 | -34.3% | 0.00% | -100.0% |
| Q1 2022 | $560,000 | +4.9% | 48,651 | -9.0% | 0.00% | 0.0% |
| Q4 2021 | $534,000 | -22.2% | 53,489 | +1.9% | 0.00% | 0.0% |
| Q3 2021 | $686,000 | -42.3% | 52,492 | -13.6% | 0.00% | 0.0% |
| Q2 2021 | $1,189,000 | -2.8% | 60,739 | +5.7% | 0.00% | -50.0% |
| Q1 2021 | $1,223,000 | -18.8% | 57,485 | +13.4% | 0.00% | 0.0% |
| Q4 2020 | $1,507,000 | +37.2% | 50,685 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,098,000 | -2.8% | 50,685 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,130,000 | +64.0% | 50,685 | +11.9% | 0.00% | +100.0% |
| Q1 2020 | $689,000 | -33.0% | 45,288 | +1.2% | 0.00% | -50.0% |
| Q4 2019 | $1,028,000 | +33.0% | 44,766 | +25.0% | 0.00% | 0.0% |
| Q3 2019 | $773,000 | -0.6% | 35,799 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $778,000 | +21.8% | 35,372 | +51.8% | 0.00% | +100.0% |
| Q1 2019 | $639,000 | +1.3% | 23,306 | -0.8% | 0.00% | 0.0% |
| Q4 2018 | $631,000 | -6.7% | 23,491 | +1.4% | 0.00% | 0.0% |
| Q3 2018 | $676,000 | +15.4% | 23,158 | +23.5% | 0.00% | 0.0% |
| Q2 2018 | $586,000 | +131.6% | 18,758 | +47.4% | 0.00% | 0.0% |
| Q1 2018 | $253,000 | -32.9% | 12,730 | -2.0% | 0.00% | 0.0% |
| Q4 2017 | $377,000 | – | 12,986 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |